Business Context and Reporting Period
This Form 8-K Current Report was filed by TopSpin Medical, Inc. (not My Size, Inc.) on April 2, 2009. The registrant is incorporated in Delaware and maintains its principal executive offices in Lod, Israel. The report addresses a specific corporate governance event rather than periodic financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding personnel changes and does not contain financial statements or operational metrics.
Material Changes
The material change reported is the departure of a senior officer:
- Resignation: Ms. Tami Sharbit-Bachar notified the Company of her resignation as Director of Finance and Secretary on April 2, 2009.
- Transition Period: Pursuant to her amended employment agreement, Ms. Sharbit-Bachar will continue in her position for 45 days following the date of notice, or until a mutually agreed-upon earlier date.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks, contingencies, or unusual items were disclosed in this report other than the standard implications of an officer's departure.
Investor Verification Checklist
- Verify the appointment of a replacement for the Director of Finance and Secretary roles.
- Confirm the exact end date of Ms. Sharbit-Bachar's transition period (45 days from April 2, 2009).
- Review the referenced Exhibit 10.2 (amended employment agreement) for details on severance or post-employment obligations.
- Check subsequent filings for any impact on the Company's financial reporting capabilities during the transition.